Impact of Adherence to Interferons in the Treatment of Multiple Sclerosis

Adherence to Medication

Lars Osterberg, Terrence F. Blaschke · New England Journal of Medicine · 2005 · 7.9K citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +14

Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis

Diane L. Cookfair, Richard A. Rudick, Robert M. Herndon et al. · Annals of Neurology · 1996 · 2.4K citations

Pharmacy, Neurology, Pharmacotherapy +12

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

George A. Schumacher, Gilbert W. Beebe, Robert F. Kibler et al. · Annals of the New York Academy of Sciences · 1965 · 1.4K citations

Life Sciences, Neurology, Neuroscience +10

Disease modifying therapies in multiple sclerosis: Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED]

Douglas S. Goodin, Gerald Garmany, June Halper et al. · Neurology · 2002 · 802 citations · Full text

Life Sciences, Neurology, Neuroscience +12

A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases

Andrew M. Peterson, David P. Nau, Joyce A. Cramer et al. · Value in Health · 2006 · 633 citations

Pharmacy, Clinical Pharmacy, Pharmacy Practice +14